Page last updated: 2024-08-22

betamethasone valerate and calcitriol

betamethasone valerate has been researched along with calcitriol in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's12 (54.55)18.2507
2000's7 (31.82)29.6817
2010's3 (13.64)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Nieboer, C; Verburgh, CA1
Berth-Jones, J; Claudy, A; Cunliffe, WJ; Fairiss, G; Goldin, D; Gratton, D; Henderson, CA; Holden, CA; Maddin, WS; Ortonne, JP1
De Hoop, D; Gjertsen, BT; Karlsmark, T; Kragballe, K; Larkö, O; Nieboer, C; Roed-Petersen, J; Strand, A; Tikjøb, G; van de Kerkhof, PC1
Gniadecki, R; Kobayasi, T; Serup, J1
Gniadecka, M; Gniadecki, R; Serup, J1
Corbett, MS; Downess, N; Hutchinson, PE; Johnsson, MK; Klaber, MR; Kragballe, K; Molin, L; Pedvis-Leftick, A; Reunala, TL; Van de Kerkhof, PC1
Glade, CP; Van De Kerkhof, PC; Van Erp, PE1
Bangha, E; Elsner, P1
Cutler, TP; Downes, N; Helander, I; Molin, L; Nyfors, B1
Lorenz, B; Ruzicka, T1
Goh, CL; Khoo, BP; Tay, YK1
Abdulla, SA; Abuzariba, O; al-Taweel, M; Duweb, GA; Rahim, M1
Basak, PY; Ergin, S1
Ambroziak, M; Langner, A; Stapór, W1
Kowalzick, L1
Andreassi, L; Giannetti, A; Milani, M1
Goh, CL; Machin, D; Suresh, S; Tan, SH; Theng, CT; Wong, HB1
Chimenti, S; Esposito, M; Frangione, V; Grodzińska, A; Kapińska-Mrowiecka, M; Naldi, L; Ortonne, JP1
Clonier, F; Lacour, JP; Nørremark, K; Queille-Roussel, C; Rosen, M1
Asano, Y; Hau, CS; Kadono, T; Kamata, M; Mitsui, A; Sato, S; Shibata, S; Shimizu, T; Sugaya, M; Tada, Y; Takeoka, S; Watanabe, S1

Reviews

1 review(s) available for betamethasone valerate and calcitriol

ArticleYear
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.
    The British journal of dermatology, 2001, Volume: 144 Suppl 58

    Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Drug Therapy, Combination; Female; Humans; Male; Psoriasis; Ultraviolet Therapy

2001

Trials

17 trial(s) available for betamethasone valerate and calcitriol

ArticleYear
Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.
    Journal of the American Academy of Dermatology, 1992, Volume: 26, Issue:5 Pt 1

    Topics: Betamethasone Valerate; Calcitriol; Canada; Dermatologic Agents; Double-Blind Method; Drug Tolerance; Female; France; Humans; Ireland; Male; Ointments; Patient Dropouts; Psoriasis; United Kingdom

1992
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.
    Lancet (London, England), 1991, Jan-26, Volume: 337, Issue:8735

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone Valerate; Calcitriol; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Severity of Illness Index

1991
Psoriasis and calcipotriol.
    British journal of hospital medicine, 1991, Volume: 46, Issue:1

    Topics: Betamethasone Valerate; Calcitriol; Double-Blind Method; Humans; Ointments; Prospective Studies; Psoriasis

1991
Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis.
    The British journal of dermatology, 1994, Volume: 131, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Scalp Dermatoses; Solutions

1994
Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparat
    The British journal of dermatology, 1996, Volume: 135, Issue:3

    Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Cell Division; Clobetasol; Dermatologic Agents; DNA; Drug Administration Schedule; Drug Therapy, Combination; Epidermis; Flow Cytometry; Glucocorticoids; Humans; Keratins; Psoriasis; Vimentin

1996
Evaluation of topical antipsoriatic treatment by chromametry, visiometry and 20-MHz ultrasound in the psoriasis plaque test.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1996, Volume: 9, Issue:5

    Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Colorimetry; Dermatologic Agents; Evaluation Studies as Topic; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Single-Blind Method; Skin; Skin Pigmentation; Ultrasonography

1996
Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    The British journal of dermatology, 1997, Volume: 136, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Chronic Disease; Dermatologic Agents; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Treatment Outcome

1997
Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study.
    The British journal of dermatology, 1998, Volume: 138, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Severity of Illness Index

1998
Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis.
    International journal of dermatology, 1999, Volume: 38, Issue:7

    Topics: Adult; Aged; Amyloidosis; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Double-Blind Method; Female; Humans; Leg Dermatoses; Lichenoid Eruptions; Male; Middle Aged; Ointments; Pilot Projects; Pruritus; Skin; Time Factors; Treatment Outcome

1999
Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    International journal of clinical pharmacology research, 2000, Volume: 20, Issue:3-4

    Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Child; Dermatologic Agents; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome

2000
Comparative effects of calcipotriol and betamethasone 17-valerate solution in the treatment of seborrhoeic dermatitis of the scalp.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2001, Volume: 15, Issue:1

    Topics: Betamethasone Valerate; Calcitriol; Dermatitis, Seborrheic; Dermatologic Agents; Glucocorticoids; Humans; Scalp Dermatoses; Solutions

2001
Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland.
    The British journal of dermatology, 2001, Volume: 144 Suppl 58

    Topics: Administration, Cutaneous; Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Chronic Disease; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Prospective Studies; Psoriasis

2001
Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.
    The British journal of dermatology, 2001, Volume: 144 Suppl 58

    Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Drug Therapy, Combination; Female; Humans; Male; Psoriasis; Ultraviolet Therapy

2001
Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
    The British journal of dermatology, 2003, Volume: 148, Issue:1

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone Valerate; Calcitriol; Cross-Over Studies; Dermatologic Agents; Drug Carriers; Female; Glucocorticoids; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Single-Blind Method; Treatment Outcome

2003
A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus.
    The Journal of dermatological treatment, 2004, Volume: 15, Issue:3

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Female; Glucocorticoids; Humans; Lichen Planus; Male; Middle Aged; Ointments; Severity of Illness Index; Treatment Outcome

2004
Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:9

    Topics: Anti-Inflammatory Agents; Bandages; Betamethasone; Betamethasone Valerate; Calcitriol; Chronic Disease; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Single-Blind Method

2014
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
    Clinical drug investigation, 2017, Volume: 37, Issue:4

    Topics: Adult; Aerosols; Betamethasone; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Single-Blind Method; Treatment Outcome

2017

Other Studies

5 other study(ies) available for betamethasone valerate and calcitriol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Psoriasis treatment with vitamin D3 analogue MC 903.
    The British journal of dermatology, 1992, Volume: 126, Issue:3

    Topics: Betamethasone Valerate; Calcitriol; Humans; Psoriasis

1992
Ultrastructure of murine epidermis treated with the vitamin D3 analogue KH-1060.
    Acta dermato-venereologica, 1995, Volume: 75, Issue:3

    Topics: Administration, Cutaneous; Animals; Atrophy; Betamethasone Valerate; Calcitriol; Cell Differentiation; Cell Division; Cytoplasm; Cytoplasmic Granules; Desmosomes; Epidermis; Female; Hyalin; Intermediate Filaments; Keratinocytes; Keratins; Mice; Mice, Hairless; Microscopy, Electron; Mitochondria; Ribosomes

1995
Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060--a potent 20-epi analogue of 1,25-dihydroxyvitamin D3.
    British journal of pharmacology, 1994, Volume: 113, Issue:2

    Topics: Animals; Atrophy; Betamethasone Valerate; Calcitriol; Calcium; Epidermis; Female; Glucocorticoids; Glycosaminoglycans; Hydroxyproline; Immunosuppressive Agents; Mice; Mice, Hairless; Mice, Inbred C3H; Skin; Skinfold Thickness; Sulfur Radioisotopes

1994
The vitamin D
    Journal of dermatological science, 2018, Volume: 92, Issue:2

    Topics: Adoptive Transfer; Animals; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Down-Regulation; Female; Humans; Imiquimod; Interleukin-17; Interleukin-23; Mice; Mice, Inbred BALB C; Psoriasis; Skin; T-Lymphocytes, Regulatory; Treatment Outcome

2018